Aurinia Pharmaceuticals (AUPH) Invested Capital (2023 - 2026)
Aurinia Pharmaceuticals' (AUPH) quarterly Invested Capital came in at $64.7 million in Q1 2026, down 9.3% YoY from $71.3 million in Q1 2025, and down 6.02% on a QoQ basis from $68.8 million in Q4 2025.
Aurinia Pharmaceuticals (AUPH) Invested Capital (2023 - 2026) Analysis & Trends
Aurinia Pharmaceuticals (AUPH) has 4 years of Invested Capital data on file, last reported at $64.7 million in Q1 2026.
- Quarterly Invested Capital fell 9.3% year-over-year to $64.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $281.0 million (down 7.45% YoY) and the FY2025 annual result came in at $68.8 million, down 5.17% from the prior year.
- Invested Capital slipped to $64.7 million in Q1 2026, from $68.8 million in the prior quarter.
- In the past five years, Invested Capital ranged from a high of $93.4 million in Q2 2023 to a low of $64.7 million in Q1 2026.
- A 4-year average of $77.9 million and a median of $77.1 million in 2024 frame the typical range for Invested Capital.
- Annual changes were most pronounced in 2024 — Invested Capital declined 19.42% — and 2025, when it dropped 4.29%.
- Tracing AUPH's Invested Capital over 4 years: stood at $90.1 million in 2023, then decreased by 19.42% to $72.6 million in 2024, then declined by 5.17% to $68.8 million in 2025, then declined by 6.02% to $64.7 million in 2026.
- The last three Invested Capital figures came in at $64.7 million (Q1 2026), $68.8 million (Q4 2025), and $72.0 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 190.90 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 2.57 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 380.00 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Aurinia Pharmaceuticals | 2.06 Bn | 1.61 Bn | 76.67 Mn | 60.42 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 60.42 Mn |
| Mar 31, 2026 | 64.70 Mn |
| Dec 31, 2025 | 68.85 Mn |
| Sep 30, 2025 | 72.04 Mn |
| Jun 30, 2025 | 75.45 Mn |
| Mar 31, 2025 | 71.34 Mn |
| Dec 31, 2024 | 72.60 Mn |
| Sep 30, 2024 | 80.88 Mn |
| Jun 30, 2024 | 78.83 Mn |
| Mar 31, 2024 | 81.20 Mn |
| Dec 31, 2023 | 90.10 Mn |
| Sep 30, 2023 | 85.52 Mn |
| Jun 30, 2023 | 93.44 Mn |